These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release. Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396 [TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness. Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700 [TBL] [Abstract][Full Text] [Related]
5. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique. Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857 [TBL] [Abstract][Full Text] [Related]
6. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
7. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
8. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol. Yoncheva K; Lambov N; Miloshev S Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298 [TBL] [Abstract][Full Text] [Related]
9. Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering. Qodratnama R; Serino LP; Cox HC; Qutachi O; White LJ Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():230-6. PubMed ID: 25492193 [TBL] [Abstract][Full Text] [Related]
10. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. Jiang G; Woo BH; Kang F; Singh J; DeLuca PP J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925 [TBL] [Abstract][Full Text] [Related]
11. Erosion of biodegradable block copolymers made of poly(D,L-lactic acid) and poly(ethylene glycol). von Burkersroda F; Gref R; Göpferich A Biomaterials; 1997 Dec; 18(24):1599-607. PubMed ID: 9613807 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM; Kim SW Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123 [TBL] [Abstract][Full Text] [Related]
14. In-situ forming PLGA implants: Towards less toxic solvents. Ramos F; Willart JF; Neut C; Agossa K; Siepmann J; Siepmann F Int J Pharm; 2024 May; 657():124121. PubMed ID: 38621617 [TBL] [Abstract][Full Text] [Related]
15. Surface Mechanical and Rheological Behaviors of Biocompatible Poly((D,L-lactic acid-ran-glycolic acid)-block-ethylene glycol) (PLGA-PEG) and Poly((D,L-lactic acid-ran-glycolic acid-ran-ε-caprolactone)-block-ethylene glycol) (PLGACL-PEG) Block Copolymers at the Air-Water Interface. Kim HC; Lee H; Khetan J; Won YY Langmuir; 2015 Dec; 31(51):13821-33. PubMed ID: 26633595 [TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins. Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292 [TBL] [Abstract][Full Text] [Related]
17. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles. Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975 [TBL] [Abstract][Full Text] [Related]
18. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Blanco D; Alonso MJ Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633 [TBL] [Abstract][Full Text] [Related]
19. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method. Pérez C; De Jesús P; Griebenow K Int J Pharm; 2002 Nov; 248(1-2):193-206. PubMed ID: 12429473 [TBL] [Abstract][Full Text] [Related]
20. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells. Moffatt S; Cristiano RJ Int J Pharm; 2006 Jul; 317(1):10-3. PubMed ID: 16713147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]